HALOZYME THERAPEUTICS, INC. (HALO) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Product sales, net						53.4	46.1	37.8
Royalties						51.0	31.0	9.4
Other						42.3	58.0	28.1
Total revenues [+]	443.3	267.6	196.0	151.9	316.6	146.7	135.1	75.3
Royalties						51.0	31.0	9.4
Products						53.4	46.1	37.8
License and services						42.3	58.0	28.1
Revenue growth [+]	65.7%	36.5%	29.1%	-52.0%	115.8%	8.6%	79.3%	37.5%
Product sales, net						15.9%	21.8%	54.8%
Royalties						64.6%	228.6%	28460.6%
Cost of goods sold	81.4	43.4	45.5	10.1	31.2	33.2	29.2	22.7
Gross profit	361.9	224.2	150.4	141.7	285.5	113.5	105.8	52.6
Gross margin	81.6%	83.8%	76.8%	93.3%	90.2%	77.4%	78.3%	69.8%
Selling, general and administrative	50.3	45.7	77.3	60.8	53.8	45.9	40.0	35.9
Research and development	35.7	34.2	140.8	150.3	150.6	150.8	93.2	79.7
EBITDA [+]	278.9	147.5	-63.5	-66.9	83.2	-80.8	-25.8	-61.3
EBITDA growth	89.0%	-332.2%	-5.1%	-180.5%	-202.9%	213.5%	-57.9%	-22.6%
EBITDA margin	62.9%	55.1%	-32.4%	-44.1%	26.3%	-55.1%	-19.1%	-81.3%
Depreciation and amortization	3.0	3.3	4.1	2.4	2.2	2.4	1.7	1.8
EBIT [+]	275.9	144.3	-67.6	-69.3	81.0	-83.2	-27.5	-63.0
EBIT growth	91.3%	-313.4%	-2.5%	-185.6%	-197.3%	203.1%	-56.5%	-21.6%
EBIT margin	62.2%	53.9%	-34.5%	-45.7%	25.6%	-56.7%	-20.3%	-83.7%
Interest expense, net [+]	7.5	20.4	11.6	18.0	22.0	20.0	5.2	5.3
Interest expense	7.5	20.4	11.6	18.0	22.0	20.0	5.2	5.6
Interest income								0.2
Other income (expense), net	-19.9	5.4	7.0	7.6	2.6	1.3	0.4
Pre-tax income	248.5	129.3	-72.3	-79.8	61.6	-101.9	-32.2	-68.4
Income taxes	-154.2	0.2	0.0	0.5	-1.4	1.2	0.0	0.0
Tax rate		0.2%	0.0%				0.0%	0.0%
Net income	402.7	129.1	-72.2	-80.3	63.0	-103.0	-32.2	-68.4
Net margin	90.8%	48.2%	-36.9%	-52.9%	19.9%	-70.2%	-23.9%	-90.8%

Basic EPS [+]	$2.86	$0.95	($0.50)	($0.56)	$0.46	($0.81)	($0.25)	($0.56)
Growth	202.1%	-289.3%	-10.5%	-221.2%	-157.3%	216.5%	-54.4%	-24.7%
Diluted EPS [+]	$2.74	$0.91	($0.50)	($0.56)	$0.45	($0.81)	($0.25)	($0.56)
Growth	200.6%	-282.3%	-10.5%	-223.5%	-156.2%	216.5%	-54.4%	-24.7%

Shares outstanding (basic) [+]	140.6	136.2	144.3	143.6	136.4	128.0	126.7	122.7
Growth	3.3%	-5.6%	0.5%	5.3%	6.6%	1.0%	3.3%	8.8%
Shares outstanding (diluted) [+]	146.8	141.5	144.3	143.6	139.1	128.0	126.7	122.7
Growth	3.8%	-2.0%	0.5%	3.3%	8.7%	1.0%	3.3%	8.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.